Alternatives to time-consuming, error-prone operations promise to reduce vaccine manufacturing costs and improve facility flexibility.
Leonard Mestrandrea
Advertisement
LeonardMestrandrea is principal of Mestrandrea Consulting LLC.
Articles by Leonard Mestrandrea
Advertisement
Latest Updated Articles
Moving to Closed Systems for Aseptic ProcessingPublished: November 15th 2017 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Industry Leaders Detail Transformational Strategies to Mainstream CAR-T Care
2
Why Flexibility and Commercial Viability Must Be Built-in Early for Scaling CGTs
3
Analyzing the Safety and Scope of Next-Generation Gene Editing Platforms
4
How Rentschler Biopharma’s New Platforms Aim to Accelerate Biologics Development in Asia
5
